Gore begins long trek to pay back Bard in vascular graft patent ruling

W.L. Gore & Associates paid C.R. Bard ($BCR) the first $36 million of the $857.4 million-plus it owes its archrival now that a federal judge has affirmed Bard's victory in a years-long vascular graft patent suit. MassDevice, citing court documents, reported that the initial payment covers royalties owed Bard from July 1 through Sept. 30, 2013. The stent dispute dates back to the 1970s. Gore had argued that one of its engineers helped invent a polymer material used in Bard's vascular stent graft, but Bard asserted it had legal rights to the patent. Gore uses the material to develop both fabrics and surgical devices. A federal jury ruled in Bard's favor in 2007, and the appeals process has failed for Gore ever since. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.